Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
Ksenija Stach, Professur für Endokrinologie und Diabetologie at HMU Health and Medical University, shared a post on LinkedIn:
“Is this the future of lipid-lowering therapy?
Exciting insights from EAS 2026 in Athens:
The presented data on PCSK9 targeting, base editing, and epigenetic approaches demonstrate how rapidly lipid therapy is evolving.
From traditional LDL–C lowering therapies, small molecules, mAbs, and RNAi to potential ‘one-and-done’ treatments, we may be witnessing a true paradigm shift:
- durable LDL-C reduction after a single treatment
- new approaches to improve adherence and persistence
- epigenetic regulation instead of permanent genetic modification
- impressive preclinical and early clinical data
What I found particularly fascinating was the discussion around whether we are moving from chronic treatment strategies toward long-lasting molecular interventions.
At the same time, important questions remain:
- long-term safety
- reversibility
- cost and accessibility
- ethical considerations of genetic interventions
Still, the direction is becoming increasingly clear:
cardiovascular prevention could be fundamentally redefined over the coming years.
What do you think — are we witnessing the beginning of a new era in lipid-lowering therapy?”
Stay updated with Hemostasis Today.
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership
-
May 31, 2026, 14:31Mirjam Teboe: The Golden Rule Behind Reliable Lupus Anticoagulant Testing
-
May 31, 2026, 14:20Improving Access to Care for People Living with Haemophilia and Haemoglobinopathies – NNHF
-
May 31, 2026, 14:07Khadija Mohamed: Beyond Localized Fat – The Hidden Risks of Mesotherapy in Undiagnosed Lipedema